KPIs & Operating Metrics(New)

National Health Investors (NHI) Net Income towards Common Stockholders (2016 - 2026)

National Health Investors filings provide 15 years of Net Income towards Common Stockholders readings, the most recent being $40.0 million for Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 17.33% to $40.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $147.9 million, a 4.84% increase, with the full-year FY2025 number at $142.0 million, up 2.98% from a year prior.
  • Net Income towards Common Stockholders hit $40.0 million in Q1 2026 for National Health Investors, up from $38.1 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $43.2 million in Q4 2024 to a low of $1.9 million in Q4 2022.
  • Median Net Income towards Common Stockholders over the past 5 years was $34.3 million (2022), compared with a mean of $32.1 million.
  • The widest YoY moves for Net Income towards Common Stockholders: up 1619.11% in 2023, down 14.92% in 2023.
  • National Health Investors' Net Income towards Common Stockholders stood at $1.9 million in 2022, then surged by 1619.11% to $32.0 million in 2023, then skyrocketed by 34.93% to $43.2 million in 2024, then decreased by 11.8% to $38.1 million in 2025, then increased by 5.01% to $40.0 million in 2026.
  • The last three reported values for Net Income towards Common Stockholders were $40.0 million (Q1 2026), $38.1 million (Q4 2025), and $32.8 million (Q3 2025) per Business Quant data.